Risk assessment in inoperable chronic thromboembolic pulmonary hypertension
Event: ESC Congress 2022
Topic: Pulmonary Hypertension
Session: Chronic thromboembolic pulmonary hypertension: the best of all, but more to learn
Risk assessment tool implementation in congenital heart disease associated pulmonary arterial hypertension
Event: ESC Congress 2021 - The Digital Experience
Topic: Pulmonary Hypertension
Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters
Kynurenine-PARP 1 link mediated by microRNA 210 may be dysregulated in pulmonary hypertension
Event: ESC Congress 2020
Topic: Pathophysiology and Mechanisms
Session: Burning News from Pulmonary Vascular Disease
Evaluation of the REVEAL 2.0 simplified three-category model in a pulmonary arterial hypertension cohort enriched with congenital heart disease
Event: ESC Congress 2020
Topic: Pulmonary Hypertension
Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters
A comprehensive risk assessment at early follow-up determines prognosis better than at diagnosis in pulmonary arterial hypertension
Event: ESC Congress 2018
Topic: Pulmonary Hypertension
Session: Pulmonary hypertension: diagnosis and risk assessment
Increased DNA damage in patients with pulmonary hypertension
Event: ESC Congress 2018
Topic: Pulmonary Hypertension
Session: Pulmonary hypertension: diagnosis and risk assessment
The association between osteocalcin and epicardial fat tissue in obesity
Event: ESC Congress 2017
Topic: Nutrition
Session: Prevention - Obesity
ESC 365 is supported by
